Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABEONA THERAPEUTICS INC.ABEO · Entity 5808 | Director | May 20, 2020 | May 22, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABEONA THERAPEUTICS INC.
Report date May 20, 2020 · Filed May 22, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 97,463 |
Reported balance
After 2020-05-20 transaction · row 1
1 source rowRow 1 · 2020-05-20 · Grant · Acquired 17,969 · Balance 97,463 F1: All of the restricted stock will vest on November 20, 2020. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.20 · Expires 2030-05-20 | Direct | 21,518 |
Reported balance
After 2020-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-05-20 · Grant · Acquired 21,518 · Balance 21,518 F2: All of the stock options will vest on November 20, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: All of the restricted stock will vest on November 20, 2020.
F2: All of the stock options will vest on November 20, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2020 Filed May 22, 2020 22:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 21,518 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001493152-20-009760 · ownership.xml · derivative · entry 2 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,518 Underlying: Common Stock · 21,518 shares Expires 2030-05-20 F2 · derivative.exercise_date: All of the stock options will vest on November 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantCommon Stock | 17,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-009760 · ownership.xml · nonDerivative · entry 1 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,463 F1 · shares: All of the restricted stock will vest on November 20, 2020. Read SEC document |
| May 21, 2019 Filed May 23, 2019 22:27 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 19,827 | $0.00 Strike: $7.42 | $0.00 |
DisclosureSEC source: 0001144204-19-028029 · tv522354_4.xml · derivative · entry 1 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,827 Underlying: Common stock · 19,827 shares Expires 2029-05-21 Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 22:39 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | PurchaseCommon stock | 4,000 | $7.77 | $31,080.00 |
DisclosureSEC source: 0001144204-19-019115 · tv518674_form4.xml · nonDerivative · entry 1 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,494 F1 · balance_after: The reporting person has been delinquent in his Section 16 reporting and will file outstanding reports as soon as reasonably practicable. The amount reported in this Column 5 accounts for all prior transactions in the Issuer's common stock that have not been reported. Read SEC document |
| December 14, 2017 Filed May 22, 2019 21:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · derivative · entry 13 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2027-12-14 F2 · derivative.exercise_date: Vests 100% six months after grant date. Read SEC document |
| December 13, 2016 Filed May 22, 2019 21:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · derivative · entry 12 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock · 50,000 shares Expires 2026-12-13 F2 · derivative.exercise_date: Vests 100% six months after grant date. Read SEC document |
| February 11, 2016 Filed May 22, 2019 21:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.31 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · derivative · entry 11 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock · 50,000 shares Expires 2026-02-11 F2 · derivative.exercise_date: Vests 100% six months after grant date. Read SEC document |
| May 11, 2015 Filed May 22, 2019 21:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $7.34 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · derivative · entry 10 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common stock · 75,000 shares Expires 2025-05-11 F2 · derivative.exercise_date: Vests 100% six months after grant date. Read SEC document |
| May 11, 2015 Filed May 22, 2019 21:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantCommon stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · nonDerivative · entry 2 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,495 Read SEC document |
| March 07, 2014 Filed May 22, 2019 21:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $18.50 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · derivative · entry 9 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common stock · 10,000 shares Expires 2024-03-07 F1 · derivative.exercise_price: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F2 · derivative.exercise_date: Vests 100% six months after grant date. F1 · derivative.underlying_shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · balance_after: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. Read SEC document |
| December 11, 2012 Filed May 22, 2019 21:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · derivative · entry 8 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common stock · 2,000 shares Expires 2022-12-11 F1 · derivative.exercise_price: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F2 · derivative.exercise_date: Vests 100% six months after grant date. F1 · derivative.underlying_shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · balance_after: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. Read SEC document |
| May 24, 2012 Filed May 22, 2019 21:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 700 | $0.00 Strike: $30.50 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · derivative · entry 7 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 Underlying: Common stock · 700 shares Expires 2022-05-24 F1 · derivative.exercise_price: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F2 · derivative.exercise_date: Vests 100% six months after grant date. F1 · derivative.underlying_shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · balance_after: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. Read SEC document |
| January 23, 2012 Filed May 22, 2019 21:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantCommon stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · nonDerivative · entry 1 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495 F1 · shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · balance_after: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. Read SEC document |
| May 26, 2011 Filed May 22, 2019 21:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 700 | $0.00 Strike: $113.50 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · derivative · entry 6 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 Underlying: Common stock · 700 shares Expires 2021-05-26 F1 · derivative.exercise_price: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F2 · derivative.exercise_date: Vests 100% six months after grant date. F1 · derivative.underlying_shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · balance_after: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. Read SEC document |
| May 26, 2010 Filed May 22, 2019 21:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 600 | $0.00 Strike: $122.50 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · derivative · entry 5 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Common stock · 600 shares Expires 2020-05-26 F1 · derivative.exercise_price: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F2 · derivative.exercise_date: Vests 100% six months after grant date. F1 · derivative.underlying_shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · balance_after: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. Read SEC document |
| May 27, 2009 Filed May 22, 2019 21:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 200 | $0.00 Strike: $69.00 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · derivative · entry 4 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 Underlying: Common stock · 200 shares Expires 2019-05-27 F1 · derivative.exercise_price: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F2 · derivative.exercise_date: Vests 100% six months after grant date. F1 · derivative.underlying_shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · balance_after: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. Read SEC document |
| May 27, 2009 Filed May 22, 2019 21:10 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 500 | $0.00 Strike: $69.00 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · derivative · entry 3 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common stock · 500 shares Expires 2019-05-27 F1 · derivative.exercise_price: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F2 · derivative.exercise_date: Vests 100% six months after grant date. F1 · derivative.underlying_shares: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. F1 · balance_after: The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.